Comprehensive carrier screening with
personalized residual risk
Sema4 Elements™ Expanded Carrier Screen with Personalized Residual Risk (ECS) solution, our latest advancement in carrier screening, provides a patient’s residual risk assessment based on their molecular ancestry rather than self-reported ethnicity, for better accuracy. It offers a variety of flexible panel sizes, with screening for up to 502 genes, and may be easily customized to address specific clinical needs. With its advanced platform, Sema4 Expanded Carrier Screen enables providers to identify more at-risk pregnancies and maximize the opportunity for couples to make informed reproductive decisions.
Onset in childhood or early adulthood and progressive severity
- In-network with the majority of national and regional insurers
- Patient-friendly billing policies, including competitive self-pay prices and financial assistance programs
- We appeal coverage determinations on behalf of patients if precertification or pre-authorization requests are denied
- Patients can track their tests, view results, and access educational materials through the Sema4 Patient Portal
*Expanded Carrier Screening (502 genes) with Personalized Residual Risk [Validation Summary]. Sema4 (2021).